A candid conversation on how small biotechs can build lean clinical development teams, decide what to keep in-house, work smarter with vendors, and protect their critical path without overbuilding.

How do you build a biotech team that is lean, accountable, and ready to execute?

In the first episode of Season 4 of Cut The Chat, Life Science Insider, Sabine Hutchison speaks with Ross Pettit, Chief Development Officer at Kestrel Therapeutics, about the practical realities of building a clinical development function in a small biotech.

Ross brings more than 30 years of clinical development experience across pharma and biotech, and in this conversation, he shares a clear view on what small sponsors should keep close, what they should outsource, and why senior experience early can make all the difference.

Together, Sabi ...